XBIT - XBiotech Inc
IEX Last Trade
6.44
-0.510 -7.919%
Share volume: 41,779
Last Updated: Fri 30 Aug 2024 09:50:38 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.95
-0.51
-7.34%
Summary score
9%
Profitability
0%
Dept financing
1%
Liquidity
75%
Performance
3%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-2.2%
Return on assets
-2.72%
Return on sales
-562.74%
Return on invested capital
-23.7%
Total debt ratio
2.34%
Debt ratio change over timeo
-1.13%
Current Ratio
61.12%
Quick Ratio
66.43%
Cash Position Ratio
51.27%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-2.52%
Return on assets
-3.9%
Return on sales
-2720.67%
Return on invested capital
-27.47%
Total debt ratio
2.52%
Debt ratio change over timeo
-1.16%
Current Ratio
49.89%
Quick Ratio
49.89%
Cash Position Ratio
37.81%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-3.31%
Return on assets
-3.71%
Return on sales
0%
Return on invested capital
-37%
Total debt ratio
3.02%
Debt ratio change over time
-1.39%
Current Ratio
38.61%
Quick Ratio
38.61%
Cash Position Ratio
38.19%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-88.16%
Return on assets
-85.41%
Return on sales
2398.72%
Return on invested capital
25.18%
Total debt ratio
-113.13%
Debt ratio change over time
-1.13%
Current Ratio
-353.88%
Quick Ratio
-363.24%
Cash Position Ratio
-299.26%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XBIT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -2.2% | 7.58% | 36.15% | 7.75% |
| Return on assets | -2.72% | 2.95% | 3.44% | 5.85% |
| Return on sales | -562.74% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | -23.7% | 3.7% | 6.05% | 20.44% |
| Profitability | 0% | 41% | 68% | 80% |
| Total debt ratio | 2.34% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | -1.13% | 292.67% | 15.45% | 1.02% |
| Dept financing | 1% | 50% | 25% | 7% |
| Current Ratio | 49.89% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 49.89% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 37.81% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 1% | 2% | 4% |
| Short-term ratios | XBIT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -2.52% | 11.57% | 35.05% | 4.21% |
| Return on assets | -3.9% | 2.86% | 2.7% | 3.6% |
| Return on sales | -2720.67% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | -27.47% | 2.16% | 6.93% | 9.79% |
| Profitability | 0% | 54% | 85% | 78% |
| Total debt ratio | 2.52% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | -1.16% | 102.83% | 13.09% | 1.3% |
| Dept financing | 1% | 49% | 28% | 6% |
| Current Ratio | 49.89% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 49.89% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 37.81% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 1% | 4% | 7% |